Kanita Howard

Disclosure(s): Alnylam Pharmaceuticals: Employee (Ongoing)

Presentation(s):

• DISCOVER AMVUTTRA® (vutrisiran): A TREATMENT OPTION FOR THE POLYNEUROPATHY OF hATTR AMYLOIDOSIS

  Saturday, March 8, 2025
  12:40 PM – 1:40 PM ET

• Discover AMVUTTRA® (vutrisiran): A Treatment Option for the Polyneuropathy of hATTR Amyloidosis

  Saturday, March 8, 2025
  12:55 PM – 1:00 PM ET